The extension, released shortly before the flexibilities were set to expire at the end of 2025, gives regulators more time to ...

The Drug Enforcement Administration (DEA) published a yearlong extension of telemedicine prescribing flexibilities for ...

DEA extends telemedicine prescribing flexibilities through 2026, allowing remote controlled substance prescriptions without in-person visits.

The American Telemedicine Association announced that the U.S. Drug Enforcement Administration, or DEA, granted a 1-year ...

The Drug Enforcement Administration released a notice of proposed rulemaking that would create a three-tiered special registration system for the remote prescribing of controlled substances. An ...